Search
The National Healthcare Security Administration has recently initiated a series of symposia focused on healthcare insurance support for innovative medical devices, with the first event drawing participation from representatives of over 20 pharmaceutical companies, universities, research institutes, and medical institutions. The attendees delved into comprehensive discussions regarding the value evaluation of innovative medical devices within the healthcare insurance framework. The representatives concurred that this endeavor would contribute to the scientific assessment of innovative products' value, bolster the efficiency of healthcare insurance resource allocation, and foster distinctive and innovative advancements within the industry. Additionally, they emphasized the urgent need for the introduction of pertinent system standards and normative guidelines.
-
C114 Communication Network -
Communication Home
